<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>23(1)</volume><submitter>Seifert J</submitter><funding>Medizinische Hochschule Hannover (MHH)</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Clinical practice suggests that older adults (i.e., ≥ 65 years of age) experience adverse drug reactions (ADRs) more often than younger patients (i.e., &lt; 65 years of age). ADRs such as falls, extrapyramidal symptoms (EPS), metabolic disorders, sedation, and delirium are particularly worrisome and often associated with psychotropic drugs.&lt;h4>Methods&lt;/h4>This observational study investigated the risk for psychotropic drug-related ADRs in older (n = 99,099) and younger adults (n = 363,562) in psychiatric inpatients using data from the German pharmacovigilance program "Arzneimittelsicherheit in der Psychiatrie" (AMSP) from 1993-2016. The aim was to assess whether age influenced the risk of specific ADR types and if certain psychotropic drugs posed particular concerns.&lt;h4>Res</pubmed_abstract><journal>Annals of general psychiatry</journal><pagination>47</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11575432</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Psychotropic drug-induced adverse drug reactions in 462,661 psychiatric inpatients in relation to age: results from a German drug surveillance program from 1993-2016.</pubmed_title><pmcid>PMC11575432</pmcid><pubmed_authors>Toto S</pubmed_authors><pubmed_authors>Reinhard MA</pubmed_authors><pubmed_authors>Glocker C</pubmed_authors><pubmed_authors>Greil W</pubmed_authors><pubmed_authors>Grohmann R</pubmed_authors><pubmed_authors>Bleich S</pubmed_authors><pubmed_authors>Seifert J</pubmed_authors><pubmed_authors>Erfurth A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Psychotropic drug-induced adverse drug reactions in 462,661 psychiatric inpatients in relation to age: results from a German drug surveillance program from 1993-2016.</name><description>&lt;h4>Background&lt;/h4>Clinical practice suggests that older adults (i.e., ≥ 65 years of age) experience adverse drug reactions (ADRs) more often than younger patients (i.e., &lt; 65 years of age). ADRs such as falls, extrapyramidal symptoms (EPS), metabolic disorders, sedation, and delirium are particularly worrisome and often associated with psychotropic drugs.&lt;h4>Methods&lt;/h4>This observational study investigated the risk for psychotropic drug-related ADRs in older (n = 99,099) and younger adults (n = 363,562) in psychiatric inpatients using data from the German pharmacovigilance program "Arzneimittelsicherheit in der Psychiatrie" (AMSP) from 1993-2016. The aim was to assess whether age influenced the risk of specific ADR types and if certain psychotropic drugs posed particular concerns.&lt;h4>Res</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-07-17T01:08:21.653Z</modification><creation>2025-04-04T20:39:02.977Z</creation></dates><accession>S-EPMC11575432</accession><cross_references><pubmed>39558338</pubmed><doi>10.1186/s12991-024-00530-0</doi></cross_references></HashMap>